Chronic Genotype 5 HCV Completed Phase 2 Trials for Sofosbuvir (DB08934)

IndicationStatusPhase
DBCOND0068521 (Chronic Genotype 5 HCV)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02081079Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV InfectionTreatment